Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma 2Vomiting 1Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Colonic Neoplasms 1Burkitt Lymphoma 1

Interventions

Aprepitant 6Ondansetron 4Palonosetron 3Granisetron 3Dexamethasone 3dexamethasone 21-phosphate 2Tropisetron 2Cyclophosphamide 2Calcium Dobesilate 2dexamethasone acetate 1Yoga 1Vincristine 1Sugars 1Rituximab 1R-CHOP protocol 1Prochlorperazine 1Prednisolone 1Metoclopramide 1Lorazepam 1Immunoenzyme Techniques 1Electroacupuncture 1Doxorubicin 1Cyproheptadine 1Antiemetics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Prochlorperazine × Lymphoid × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡